(Q53379253)

13 May 2018

title

Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. (English)

1 reference

13 May 2018

author name string

Des C Jones

1

1 reference

13 May 2018

Ali Roghanian

2

1 reference

13 May 2018

Damien P Brown

3

1 reference

13 May 2018

Chiwen Chang

4

1 reference

13 May 2018

Rachel L Allen

5

1 reference

13 May 2018

John Trowsdale

6

1 reference

13 May 2018

Neil T Young

7

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 November 2009

1 reference

13 May 2018

European Journal of Immunology

published in

1 reference

13 May 2018

volume

39

1 reference

13 May 2018

issue

11

1 reference

13 May 2018

page(s)

3195-3206

1 reference

13 May 2018

Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Plasticity in the organization and sequences of human KIR/ILT gene families

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Proteolytic release of soluble UL16-binding protein 2 from tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

LIR9, an immunoglobulin-superfamily-activating receptor, is expressed as a transmembrane and as a secreted molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Arrangement of the ILT gene cluster: a common null allele of the ILT6 gene results from a 6.7-kbp deletion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

A native soluble form of CTLA-4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

The emerging role of CTLA-4 as an immune attenuator

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

The clinical utility of inhibiting CD28-mediated costimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839080

7 January 2021

Identifiers

DOI

10.1002/EJI.200839080

1 reference

13 May 2018

1 reference

13 May 2018